Publications by authors named "Donald B Fuller"

Claim this Profile
H
High Dose "HDR-Like" Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial.
Donald B Fuller, Tami Crabtree, Brent L Kane, Clinton A Medbery, Robert Pfeffer

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.
Jesus E Juarez, Tahmineh Romero, Constantine A Mantz, Abigail Pepin, Nima Aghdam, Donald B Fuller

Adv Radiat Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.
Ritchell van Dams, Naomi Y Jiang, Donald B Fuller, Andrew Loblaw, Tommy Jiang

Int J Radiat Oncol Biol Phys· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus.
Barbara A Jereczek-Fossa, Giulia Marvaso, Mattia Zaffaroni, Simone Giovanni Gugliandolo, Dario Zerini, Donald B Fuller

Cancer Treat Rev· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
Trevor J Royce, Panayiotis Mavroidis, Kyle Wang, Aaron D Falchook, Nathan C Sheets, Donald B Fuller

Int J Radiat Oncol Biol Phys· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response.
Kyle Wang, Panayiotis Mavroidis, Trevor J Royce, Aaron D Falchook, Sean P Collins, Donald B Fuller

Int J Radiat Oncol Biol Phys· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.
Rebecca G Levin-Epstein, Naomi Y Jiang, Xiaoyan Wang, Shrinivasa K Upadhyaya, Sean P Collins, Donald B Fuller

Radiother Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer.
Seth R Blacksburg, Donald B Fuller, Jonathan A Haas

Front Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate SBRT: Comparison the Efficacy and Toxicity of Two Different Dose Fractionation Schedules.
Donald Blake Fuller, John Naitoh, Reza Shirazi, Tami Crabtree, George Mardirossian

Front Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials.
Ye Yuan, Nima Aghdam, Christopher R King, Donald B Fuller, Julius Weng

Int J Radiat Oncol Biol Phys· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.
Amar U Kishan, Audrey Dang, Alan J Katz, Constantine A Mantz, Sean P Collins, Donald B Fuller

JAMA Netw Open· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial.
Kyle Wang, Ronald C Chen, Brent L Kane, Clinton A Medbery, Kelly J Underhill, Donald B Fuller

Int J Radiat Oncol Biol Phys· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes.
Donald B Fuller, Aaron D Falchook, Tami Crabtree, Brent L Kane, Clinton A Medbery

Eur Urol Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy.
John V Hegde, Sean P Collins, Donald B Fuller, Christopher R King, D Jeffrey Demanes

Am J Clin Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
Donald B Fuller, James Wurzer, Reza Shirazi, Stephen S Bridge, Jonathan Law

Pract Radiat Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual HDR CyberKnife SBRT for Localized Prostatic Carcinoma: 5-Year Disease-Free Survival and Toxicity Observations.
Donald Blake Fuller, John Naitoh, George Mardirossian

Front Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regarding relative toxicities of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer.
Donald B Fuller

J Clin Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy.
Russell N Low, Donald B Fuller, Naira Muradyan

AJR Am J Roentgenol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balancing on a knife's edge: evidence-based medicine and the marketing of health technology. In regard to Bentzen et al. (Int J Radiat Oncol Biol Phys 2008;72:12-14).
Donald B Fuller

Int J Radiat Oncol Biol Phys· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computed tomography-ultrasound fusion brachytherapy: description and evolution of the technique.
Donald B Fuller, Haoran Jin

Brachytherapy· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
Donald B Fuller, John Naitoh, Charles Lee, Steven Hardy, Haoran Jin

Int J Radiat Oncol Biol Phys· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT-ultrasound fusion prostate brachytherapy: a dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases.
Donald B Fuller, Haoran Jin, James A Koziol, Anne C Feng

Brachytherapy· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors.
Donald B Fuller, James A Koziol, Anne C Feng

Brachytherapy· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis